Table 3 Overall and sex-specific prevalence of thyroid cancer (95% CI) (N = 550)
Variable | Overall (n = 550) | Male (n = 49) | Female (n = 501) | p-value | |||
|---|---|---|---|---|---|---|---|
N | % (95% CI) | N | % (95% CI) | N | % (95% CI) | ||
Cancer (yes/no) | 76/474 | 9/40 | 67/434 | ||||
All thyroid nodules | 13.8 (10.9–16.7) | 18.4 (7.5–29.2) | 13.4 (10.4–16.4) | 0.334 | |||
Age (years) | |||||||
< 20 | 4 | 16.0 (1.6–30.4) | 0 | 0.0 (0.0–0.0) | 4 | 18.2 (2.1–34.3) | 0.420 |
21–30 | 25 | 16.7 (10.7–22.6) | 4 | 36.4 (7.9–64.8 | 21 | 15.1 (9.2–21.1) | 0.069 |
31–40 | 24 | 13.3 (8.3–18.2) | 4 | 23.5 (3.4–43.7) | 20 | 12.2 (7.2–17.2) | 0.190 |
41–50 | 14 | 12.5 (6.4–18.6) | 1 | 8.3 (0.0–24.0) | 13 | 13.0 (21.9–40.1) | 0.644 |
51–60 | 7 | 11.3 (3.4–19.2) | 0 | 0.0 (0.0–0.0) | 7 | 12.1 (3.7–20.5) | 0.461 |
> 60 | 2 | 10.0 (0.0–23.2) | 0 | 0.0 (0.0–0.0) | 2 | 11.1 (0.0–25.6) | 0.619 |